Sarah Blitz

Sarah Blitz, a senior associate and co-founder of the Cannabis Industry Team at Sheppard Mullin, shares her fascinating journey from law school to becoming a cannabis law leader. She discusses the challenges of building a nontraditional practice and emphasizes the importance of aligning personal passions with professional goals. Sarah offers insights into navigating market trends, client needs, and the ethical considerations of cannabis law. Her story showcases how entrepreneurial thinking can redefine a career in Big Law, providing guidance for associates eager to carve out their own path.

Researchers Joshua D. Bernstock, Sarah Blitz, Kyung-Don Kang, and Gregory K. Friedman discuss Intraventricular Immunovirotherapy in cancer treatment using engineered type 1 herpes simplex virus. They highlight its efficacy in recent clinical trials for high-grade glioma and potential for targeting intractable diseases like disseminated medulloblastoma. The importance of Intraventricular Administration for targeted immunovirotherapy is emphasized.